Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Venu Gopal Jonnalagadda"'
Publikováno v:
mBio, Vol 9, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/39db927b53914d2d82f94b6827165801
Autor:
Venu Gopal Jonnalagadda, Allam Venkata Sita Ram Raju, Srinivas Pittala, Afsar shaik, Nilakash Annaji Selkar
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 4, Iss 3, Pp 209-217 (2014)
Metabolic disorders are a group of disorders, due to the disruption of the normal metabolic process at a cellular level. Diabetes Mellitus and Tyrosinaemia are the majorly reported metabolic disorders. Among them, Diabetes Mellitus is a one of the le
Externí odkaz:
https://doaj.org/article/0322b4d0222041db885316218e73ce4a
Autor:
Rohit Dhumal, N.A. Selkar, M.B. Chawda, K.S. Thakur, M.K. Vahalia, Venu Gopal Jonnalagadda, Geeta Vanage
Publikováno v:
Asian Pacific Journal of Reproduction, Vol 3, Iss 1, Pp 8-12 (2014)
Objective: To evaluate the safety & efficacy of Maa-Lact granules for its galactogougue activity in Holtzman rats and its effect on suckling pups. Methods: Group I rats were treated as control, group II and III rats were treated with 500 mg/kg, 1 000
Externí odkaz:
https://doaj.org/article/4f81aaf4dcf243a598e912615d2eca3f
Publikováno v:
Clinical Hypertension, Vol 23, Iss 1, Pp 1-2 (2017)
Abstract We have read the article “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients:
Externí odkaz:
https://doaj.org/article/8b4ee689c16a4e89802e02b5662ad572
Publikováno v:
Asian Pacific Journal of Tropical Biomedicine, Vol 7, Iss 11, Pp 1023-1024 (2017)
Externí odkaz:
https://doaj.org/article/b7c7004852b14190b7cd7c0e31696756
Autor:
Venu Gopal, Jonnalagadda
Publikováno v:
In Pharmacognosy Journal May-June 2013 5(3):123-126
Publikováno v:
mBio, Vol 9, Iss 4 (2018)
mBio
mBio, Vol 9, Iss 4, p e01173-18 (2018)
mBio
mBio, Vol 9, Iss 4, p e01173-18 (2018)
Accumulating evidence implicates gut microbiota as promising targets for the treatment of type 2 diabetes mellitus (T2DM). With a randomized clinical trial, we tested the hypothesis that alteration of gut microbiota may be involved in the alleviation
Publikováno v:
Diabetes/metabolism research and reviews. 34(5)
Publikováno v:
Acta diabetologica. 55(7)
Publikováno v:
Journal of Clinical and Molecular Medicine. 1